These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23385732)

  • 1. Timing of radiotherapy in breast-conserving therapy: a large prospective cohort study of node-negative breast cancer patients without adjuvant systemic therapy.
    Jobsen JJ; van der Palen J; Baum M; Brinkhuis M; Struikmans H
    Br J Cancer; 2013 Mar; 108(4):820-5. PubMed ID: 23385732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of radiotherapy and survival benefit in breast cancer.
    Jobsen JJ; van der Palen J; Ong F; Meerwaldt JH
    Breast Cancer Res Treat; 2006 Oct; 99(3):289-94. PubMed ID: 16596325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of the timing of radiotherapy after breast-conserving surgery : Results of a large, single-centre, population-based cohort study.
    Jobsen JJ; Struikmans H; van der Palen J; Siemerink EJM
    Strahlenther Onkol; 2022 Mar; 198(3):268-281. PubMed ID: 34845511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
    Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
    J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
    Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
    Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
    Setton J; Cody H; Tan L; Morrow M; Hudis C; Catalano J; McCormick B; Powell S; Ho A
    Cancer; 2012 Apr; 118(8):1994-2003. PubMed ID: 21882186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
    Almahariq MF; Quinn TJ; Siddiqui Z; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
    Radiother Oncol; 2020 Jan; 142():186-194. PubMed ID: 31615634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalent Survival With Mastectomy or Breast-conserving Surgery Plus Radiation in Young Women Aged < 40 Years With Early-Stage Breast Cancer: A National Registry-based Stage-by-Stage Comparison.
    Ye JC; Yan W; Christos PJ; Nori D; Ravi A
    Clin Breast Cancer; 2015 Oct; 15(5):390-7. PubMed ID: 25957740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.
    van Dongen JA; Voogd AC; Fentiman IS; Legrand C; Sylvester RJ; Tong D; van der Schueren E; Helle PA; van Zijl K; Bartelink H
    J Natl Cancer Inst; 2000 Jul; 92(14):1143-50. PubMed ID: 10904087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital.
    Dinshaw KA; Sarin R; Budrukkar AN; Shrivastava SK; Deshpande DD; Chinoy RF; Badwe R; Hawaldar R
    J Surg Oncol; 2006 Aug; 94(2):105-13. PubMed ID: 16847919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
    van Maaren MC; de Munck L; Jobsen JJ; Poortmans P; de Bock GH; Siesling S; Strobbe LJA
    Breast Cancer Res Treat; 2016 Dec; 160(3):511-521. PubMed ID: 27730424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in node negative premenopausal women treated with breast conserving therapy without adjuvant systemic therapy.
    Budrukkar AN; Sarin R; Chinoy RF; Badwe R; Shrivastava SK; Dinshaw KA
    Breast; 2008 Jun; 17(3):263-9. PubMed ID: 18060781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials.
    Viani GA; Stefano EJ; Afonso SL; De Fendi LI; Soares FV; Leon PG; Guimarães FS
    Radiat Oncol; 2007 Aug; 2():28. PubMed ID: 17683529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival.
    van Maaren MC; Bretveld RW; Jobsen JJ; Veenstra RK; Groothuis-Oudshoorn CG; Struikmans H; Maduro JH; Strobbe LJ; Poortmans PM; Siesling S
    Br J Cancer; 2017 Jul; 117(2):179-188. PubMed ID: 28588320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant radiation therapy and survival for adenoid cystic carcinoma of the breast.
    Sun JY; Wu SG; Chen SY; Li FY; Lin HX; Chen YX; He ZY
    Breast; 2017 Feb; 31():214-218. PubMed ID: 27915203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.